The rearrangement results in the expression of the ETV6/RUNX1 fusion gene, which leads to increased expression of a number of genes, including the erythropoietin receptor (EPOR), compared to other subtypes of B-ALL [1–4]. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.